{"name": "Mesoblast",
 "permalink": "mesoblast",
 "crunchbase_url": "http://www.crunchbase.com/company/mesoblast",
 "homepage_url": "http://www.mesoblast.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@mesoblast.com",
 "phone_number": "+61 3 9639 6036 ",
 "description": "",
 "created_at": "Thu May 13 01:34:22 UTC 2010",
 "updated_at": "Wed Mar 27 02:38:34 UTC 2013",
 "overview": "\u003Cp\u003EMesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast\u0026#8217;s patented Mesenchymal Precursor Cell (MPC)\ntechnology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney\ndisease, orthopedic spine conditions, and cardiovascular disorders.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       38],
      "assets/images/resized/0008/6970/86970v2-max-150x150.png"],
     [[250,
       63],
      "assets/images/resized/0008/6970/86970v2-max-250x250.png"],
     [[300,
       76],
      "assets/images/resized/0008/6970/86970v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Jenni",
      "last_name": "Pilcher",
      "permalink": "jenni-pilcher",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "Paul",
      "last_name": "Rennie",
      "permalink": "paul-rennie",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Operations",
    "person":
     {"first_name": "Suzanne",
      "last_name": "Lipe",
      "permalink": "suzanne-lipe",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": "cash_and_stock",
    "source_url": "http://www.fiercebiotech.com/story/mesoblast-acquire-angioblast-and-speed-stem-cell-work/2010-05-12?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Mesoblast to acquire Angioblast and speed up stem cell work",
    "acquired_year": 2010,
    "acquired_month": 5,
    "acquired_day": 12,
    "company":
     {"name": "Angioblast Systems",
      "permalink": "angioblast-systems",
      "image":
       {"available_sizes":
         [[[150,
            50],
           "assets/images/resized/0008/6966/86966v1-max-150x150.jpg"],
          [[185,
            62],
           "assets/images/resized/0008/6966/86966v1-max-250x250.jpg"],
          [[185,
            62],
           "assets/images/resized/0008/6966/86966v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "Level 39",
    "address2": "55 Collins Street",
    "zip_code": "3000 ",
    "city": "Melbourne ",
    "state_code": null,
    "country_code": "AUS",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": 2013,
   "pub_month": 3,
   "pub_day": 14,
   "stock_symbol": "ASX:MSB"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}